Search:
Thursday, Jan-23 2020 18:10 WIB
  • AGRI 1,389.820 -4.000 (-0.287%)
  • BASIC-IND 965.950 11.940 (1.252%)
  • BISNIS-27 564.870 1.500 (0.266%)
  • COMPOSITE 6,249.210 15.760 (0.253%)
  • CONSUMER 2,078.820 6.780 (0.327%)
  • DBX 1,090.970 3.620 (0.333%)
  • FINANCE 1,375.390 1.440 (0.105%)
  • I-GRADE 180.430 0.770 (0.429%)
  • IDX30 560.120 2.030 (0.364%)
  • IDX80 143.250 0.490 (0.343%)
  • IDXBUMN20 387.380 0.480 (0.124%)
  • IDXG30 146.720 0.980 (0.672%)
  • IDXHIDIV20 504.310 1.150 (0.229%)
  • IDXSMC-COM 248.560 0.020 (0.008%)
  • IDXSMC-LIQ 305.530 0.070 (0.023%)
  • IDXV30 135.460 -0.040 (-0.030%)
  • INFOBANK15 1,055.020 1.470 (0.140%)
  • INFRASTRUC 1,096.780 5.770 (0.529%)
  • Investor33 473.610 1.180 (0.250%)
  • ISSI 182.790 0.660 (0.362%)
  • JII 686.860 3.750 (0.549%)
  • JII70 228.320 1.120 (0.493%)
  • KOMPAS100 1,279.340 3.950 (0.310%)
  • LQ45 1,024.590 3.750 (0.367%)
  • MANUFACTUR 1,465.000 9.860 (0.678%)
  • MBX 1,749.000 4.220 (0.242%)
  • MINING 1,481.190 -1.010 (-0.068%)
  • MISC-IND 1,228.450 7.750 (0.635%)
  • MNC36 355.220 1.220 (0.345%)
  • PEFINDO25 317.480 -3.270 (-1.019%)
  • PROPERTY 472.690 0.760 (0.161%)
  • SMinfra18 317.210 0.640 (0.202%)
  • SRI-KEHATI 405.120 0.950 (0.235%)
  • TOTAL_MARKET 6,249.210 15.760 (0.253%)
  • TRADE 745.220 -4.990 (-0.665%)
  • © 2010 IMQ - LKBN ANTARA
  • AALI 12,425 0 (0.00%)
  • ABBA 92 0 (0.00%)
  • ABMM 1,480 -10 (-0.67%)
  • ACES 1,620 -20 (-1.22%)
  • ACST 980 -10 (-1.01%)
  • ADES 985 5 (0.51%)
  • ADHI 1,090 -10 (-0.91%)
  • ADMF 10,275 -25 (-0.24%)
  • ADMG 178 -1 (-0.56%)
  • ADRO 1,380 15 (1.10%)
  • AGAR 392 -4 (-1.01%)
  • AGII 605 5 (0.83%)
  • AGRO 167 -3 (-1.76%)
  • AGRS 157 2 (1.29%)
  • AHAP 63 6 (10.53%)
  • AKRA 3,380 -10 (-0.29%)
  • AKSI 478 -32 (-6.27%)
  • ALDO 402 2 (0.50%)
  • ALKA 398 48 (13.71%)
  • ALMI 308 -42 (-12.00%)
  • AMAR 498 4 (0.81%)
  • AMFG 3,330 -70 (-2.06%)
  • AMIN 370 10 (2.78%)
  • AMOR 2,640 -170 (-6.05%)
  • AMRT 855 5 (0.59%) © 2010 IMQ - LKBN ANTARA
  • ANDI 50 0 (0.00%)
  • ANTM 780 10 (1.30%)
  • APIC 705 0 (0.00%)
  • APII 212 0 (0.00%)
  • APLI 168 1 (0.60%)
  • APLN 164 -1 (-0.61%)
  • ARKA 2,010 -10 (-0.50%)
  • ARNA 434 4 (0.93%)
  • ARTA 340 0 (0.00%)
  • ARTO 3,250 60 (1.88%)
  • ASBI 230 0 (0.00%)
  • ASDM 1,080 -15 (-1.37%)
  • ASGR 975 -40 (-3.94%)
  • ASII 7,050 50 (0.71%)
  • ASJT 125 2 (1.63%)
  • ASMI 1,295 0 (0.00%)
  • ASRI 212 0 (0.00%)
  • ASSA 620 -10 (-1.59%)
  • AUTO 1,230 0 (0.00%)
  • BABP 50 0 (0.00%)
  • BABP-W3 36 3 (9.09%)
  • BABP-W4 13 1 (8.33%)
  • BACA 310 2 (0.65%)
  • BAJA 80 8 (11.11%)
  • BALI 975 75 (8.33%) © 2010 IMQ - LKBN ANTARA
  • BAPA 62 0 (0.00%)
  • BAPI 50 0 (0.00%)
  • BAPI-W 6 0 (0.00%)
  • BATA 595 0 (0.00%)
  • BBCA 34,200 0 (0.00%)
  • BBHI 118 -1 (-0.84%)
  • BBKP 230 -2 (-0.86%)
  • BBNI 7,650 25 (0.33%)
  • BBRI 4,740 30 (0.64%)
  • BBTN 2,030 -20 (-0.98%)
  • BBYB 270 2 (0.75%)
  • BCAP 140 0 (0.00%)
  • BCIP 50 0 (0.00%)
  • BDMN 3,840 -20 (-0.52%)
  • BEEF 412 8 (1.98%)
  • BEEF-W 53 1 (1.92%)
  • BEKS 50 0 (0.00%)
  • BELL 535 5 (0.94%)
  • BEST 191 0 (0.00%)
  • BFIN 565 5 (0.89%)
  • BGTG 60 0 (0.00%)
  • BHIT 66 -1 (-1.49%)
  • BIKA 194 9 (4.86%)
  • BIMA 50 0 (0.00%)
  • BINA 895 5 (0.56%) © 2010 IMQ - LKBN ANTARA
  • BIPI 50 0 (0.00%)
  • BIPI-W 10 0 (0.00%)
  • BIRD 2,580 -50 (-1.90%)
  • BISI 1,020 5 (0.49%)
  • BJBR 1,060 10 (0.95%)
  • BJTM 625 -10 (-1.57%)
  • BKDP 60 1 (1.69%)
  • BKSL 72 2 (2.86%)
  • BKSL-W 16 -2 (-11.11%)
  • BKSW 157 0 (0.00%)
  • BLTZ 4,840 -20 (-0.41%)
  • BLUE 496 4 (0.81%)
  • BMAS 340 -6 (-1.73%)
  • BMRI 7,775 -25 (-0.32%)
  • BMSR 110 0 (0.00%)
  • BMTR 360 -2 (-0.55%)
  • BNBA 320 4 (1.27%)
  • BNBR 50 0 (0.00%)
  • BNGA 935 5 (0.54%)
  • BNII 204 4 (2.00%)
  • BNLI 1,205 5 (0.42%)
  • BOGA 1,355 5 (0.37%)
  • BOLA 270 0 (0.00%)
  • BOLT 855 5 (0.59%)
  • BOSS 171 1 (0.59%) © 2010 IMQ - LKBN ANTARA
  • BPFI 1,310 0 (0.00%)
  • BPTR 88 0 (0.00%)
  • BRIS 310 -6 (-1.90%)
  • BRMS 51 1 (2.00%)
  • BRPT 1,365 40 (3.02%)
  • BSDE 1,210 40 (3.42%)
  • BSIM 530 0 (0.00%)
  • BSIM-W3 40 6 (17.65%)
  • BSSR 1,880 40 (2.17%)
  • BTEK 50 0 (0.00%)
  • BTON 199 -3 (-1.49%)
  • BTPN 3,100 -20 (-0.64%)
  • BTPS 4,700 50 (1.08%)
  • BUDI 99 -1 (-1.00%)
  • BUKK 1,430 -20 (-1.38%)
  • BULL 176 -1 (-0.56%)
  • BULL-W 75 1 (1.35%)
  • BULL-W2 26 1 (4.00%)
  • BUMI 61 -2 (-3.17%)
  • BUVA 58 1 (1.75%)
  • BVIC 75 0 (0.00%)
  • BWPT 135 -5 (-3.57%)
  • CAKK 63 0 (0.00%)
  • CAKK-W 22 1 (4.76%)
  • CAMP 348 2 (0.58%) © 2010 IMQ - LKBN ANTARA
  • CARS 125 2 (1.63%)
  • CASA 414 -4 (-0.96%)
  • CASS 560 -40 (-6.67%)
  • CCSI 264 4 (1.54%)
  • CEKA 1,560 -10 (-0.64%)
  • CENT 77 -1 (-1.28%)
  • CFIN 256 -4 (-1.54%)
  • CINT 268 0 (0.00%)
  • CITY 128 -5 (-3.76%)
  • CITY-W 34 -2 (-5.56%)
  • CLAY 2,880 -140 (-4.64%)
  • CLEO 500 10 (2.04%)
  • CLPI 735 -15 (-2.00%)
  • CNTX 346 8 (2.37%)
  • COCO 855 -5 (-0.58%)
  • CPIN 7,150 100 (1.42%)
  • CPRI 50 0 (0.00%)
  • CPRI-W 22 -1 (-4.35%)
  • CSAP 440 0 (0.00%)
  • CSIS 88 3 (3.53%)
  • CSRA 404 0 (0.00%)
  • CTRA 990 15 (1.54%)
  • CTTH 64 1 (1.59%)
  • DAYA 280 26 (10.24%)
  • DEAL 157 -3 (-1.88%) © 2010 IMQ - LKBN ANTARA
  • DEFI 1,890 0 (0.00%)
  • DEWA 50 0 (0.00%)
  • DFAM 400 0 (0.00%)
  • DGIK 50 0 (0.00%)
  • DIGI 1,690 -10 (-0.59%)
  • DILD 304 0 (0.00%)
  • DIVA 2,580 -110 (-4.09%)
  • DKFT 134 -2 (-1.47%)
  • DLTA 6,500 -50 (-0.76%)
  • DMAS 274 -2 (-0.72%)
  • DMMX 218 0 (0.00%)
  • DMND 1,530 160 (11.68%)
  • DNET 3,060 -10 (-0.33%)
  • DOID 260 -4 (-1.52%)
  • DPUM 108 0 (0.00%)
  • DSFI 99 1 (1.02%)
  • DSNG 442 -4 (-0.90%)
  • DUCK 1,240 5 (0.40%)
  • DVLA 2,180 -20 (-0.91%)
  • DWGL 260 10 (4.00%)
  • DWGL-W 85 9 (11.84%)
  • DYAN 73 1 (1.39%)
  • EAST 92 -2 (-2.13%)
  • EAST-W 15 0 (0.00%)
  • ECII 1,010 -5 (-0.49%) © 2010 IMQ - LKBN ANTARA
  • EKAD 1,100 -5 (-0.45%)
  • ELSA 286 -6 (-2.05%)
  • ELTY 50 0 (0.00%)
  • EMDE 222 0 (0.00%)
  • EMTK 5,650 0 (0.00%)
  • ENRG 50 0 (0.00%)
  • ENVY 440 -52 (-10.57%)
  • EPMT 1,850 -100 (-5.13%)
  • ERAA 1,695 65 (3.99%)
  • ERTX 144 4 (2.86%)
  • ESIP 274 0 (0.00%)
  • ESIP-W 26 0 (0.00%)
  • ESSA 244 2 (0.83%)
  • ESTI 53 0 (0.00%)
  • ETWA 61 0 (0.00%)
  • EXCL 3,220 20 (0.62%)
  • FILM 218 -16 (-6.84%)
  • FIRE 226 -2 (-0.88%)
  • FITT 84 -1 (-1.18%)
  • FITT-W 60 -3 (-4.76%)
  • FOOD 112 -1 (-0.88%)
  • FORU 108 -1 (-0.92%)
  • FORZ 50 0 (0.00%)
  • FPNI 93 5 (5.68%)
  • FREN 124 -1 (-0.80%) © 2010 IMQ - LKBN ANTARA
  • FREN-W 73 -3 (-3.95%)
  • FUJI 111 4 (3.74%)
  • GAMA 50 0 (0.00%)
  • GDST 83 4 (5.06%)
  • GEMA 364 -2 (-0.55%)
  • GGRM 57,950 600 (1.05%)
  • GGRP 472 12 (2.61%)
  • GHON 1,210 -370 (-23.42%)
  • GIAA 424 -16 (-3.64%)
  • GJTL 530 -10 (-1.85%)
  • GLOB 406 -6 (-1.46%)
  • GLVA 258 -4 (-1.53%)
  • GMFI 126 12 (10.53%)
  • GMTD 19,000 3,000 (18.75%)
  • GOOD 1,390 0 (0.00%)
  • GPRA 61 -3 (-4.69%)
  • GTBO 136 3 (2.26%)
  • GWSA 141 0 (0.00%)
  • GZCO 50 0 (0.00%)
  • HDIT 635 -15 (-2.31%)
  • HEAL 3,400 0 (0.00%)
  • HELI 190 5 (2.70%)
  • HELI-W 14 0 (0.00%)
  • HERO 845 -45 (-5.06%)
  • HEXA 3,350 120 (3.72%) © 2010 IMQ - LKBN ANTARA
  • HKMU 190 -5 (-2.56%)
  • HMSP 2,170 10 (0.46%)
  • HOKI 880 5 (0.57%)
  • HOKI-W 620 0 (0.00%)
  • HOME 50 0 (0.00%)
  • HRME 1,040 15 (1.46%)
  • HRTA 250 6 (2.46%)
  • HRUM 1,350 0 (0.00%)
  • IBFN 330 -30 (-8.33%)
  • IBFN-W 23 0 (0.00%)
  • ICBP 11,700 -50 (-0.43%)
  • ICON 71 -1 (-1.39%)
  • IDPR 340 12 (3.66%)
  • IFII 204 -4 (-1.92%)
  • IGAR 336 0 (0.00%)
  • IKAI 55 0 (0.00%)
  • IKBI 270 -12 (-4.26%)
  • IMAS 1,080 -25 (-2.26%)
  • IMJS 276 -4 (-1.43%)
  • IMPC 1,110 5 (0.45%)
  • INAF 810 120 (17.39%)
  • INAI 420 0 (0.00%)
  • INCF 50 0 (0.00%)
  • INCI 400 0 (0.00%)
  • INCO 3,300 -60 (-1.79%) © 2010 IMQ - LKBN ANTARA
  • INDF 8,150 100 (1.24%)
  • INDO 147 -6 (-3.92%)
  • INDO-W 77 -3 (-3.75%)
  • INDR 2,410 60 (2.55%)
  • INDS 2,220 -20 (-0.89%)
  • INDX 54 2 (3.85%)
  • INDY 1,085 5 (0.46%)
  • INKP 8,000 50 (0.63%)
  • INOV 306 0 (0.00%)
  • INPC 58 -1 (-1.69%)
  • INPC-W 6 0 (0.00%)
  • INPP 985 0 (0.00%)
  • INPS 4,010 -20 (-0.50%)
  • INRU 795 0 (0.00%)
  • INTA 438 -12 (-2.67%)
  • INTA-W 180 0 (0.00%)
  • INTD 234 0 (0.00%)
  • INTP 18,575 225 (1.23%)
  • IPCC 570 -10 (-1.72%)
  • IPCM 170 5 (3.03%)
  • IPOL 78 0 (0.00%)
  • IPTV 416 -4 (-0.95%)
  • IPTV-W 111 -11 (-9.02%)
  • IRRA 685 -5 (-0.72%)
  • ISAT 2,390 20 (0.84%) © 2010 IMQ - LKBN ANTARA
  • ISSP 184 0 (0.00%)
  • ITIC 2,640 50 (1.93%)
  • ITMA 520 0 (0.00%)
  • ITMG 11,850 -175 (-1.46%)
  • JAST 1,680 -40 (-2.33%)
  • JAYA 85 0 (0.00%)
  • JAYA-W 21 -1 (-4.55%)
  • JMAS 835 70 (9.15%)
  • JPFA 1,580 20 (1.28%)
  • JRPT 565 -5 (-0.88%)
  • JSKY 190 -7 (-3.55%)
  • JSMR 5,050 80 (1.61%)
  • JTPE 965 0 (0.00%)
  • KAEF 1,090 65 (6.34%)
  • KARW 62 1 (1.64%)
  • KAYU 81 1 (1.25%)
  • KBLI 476 0 (0.00%)
  • KBLM 266 0 (0.00%)
  • KDSI 1,150 0 (0.00%)
  • KEEN 438 -8 (-1.79%)
  • KEJU 840 -5 (-0.59%)
  • KIAS 67 0 (0.00%)
  • KICI 230 0 (0.00%)
  • KIJA 296 2 (0.68%)
  • KINO 2,940 -50 (-1.67%) © 2010 IMQ - LKBN ANTARA
  • KIOS 420 24 (6.06%)
  • KJEN 2,010 0 (0.00%)
  • KKGI 242 -6 (-2.42%)
  • KLBF 1,575 -15 (-0.94%)
  • KMTR 316 0 (0.00%)
  • KOBX 117 1 (0.86%)
  • KONI 630 -20 (-3.08%)
  • KOPI 615 0 (0.00%)
  • KOTA 610 -15 (-2.40%)
  • KOTA-W 340 -20 (-5.56%)
  • KPAL 197 6 (3.14%)
  • KPAS 64 -2 (-3.03%)
  • KPAS-W 27 -1 (-3.57%)
  • KPIG 129 2 (1.57%)
  • KRAH 1,590 90 (6.00%)
  • KRAS 270 2 (0.75%)
  • KREN 474 8 (1.72%)
  • LAND 840 -10 (-1.18%)
  • LCKM 326 -2 (-0.61%)
  • LEAD 50 0 (0.00%)
  • LINK 3,780 30 (0.80%)
  • LMAS 130 17 (15.04%)
  • LMPI 95 8 (9.20%)
  • LMSH 446 16 (3.72%)
  • LPCK 870 -15 (-1.69%) © 2010 IMQ - LKBN ANTARA
  • LPKR 238 8 (3.48%)
  • LPLI 80 -1 (-1.23%)
  • LPPF 3,900 -120 (-2.99%)
  • LPPS 75 -2 (-2.60%)
  • LRNA 170 -10 (-5.56%)
  • LSIP 1,245 -20 (-1.58%)
  • LTLS 620 5 (0.81%)
  • LUCK 600 -30 (-4.76%)
  • MABA 50 0 (0.00%)
  • MAIN 925 10 (1.09%)
  • MAMI 50 0 (0.00%)
  • MAMI-W 16 -1 (-5.88%)
  • MAPA 4,510 -110 (-2.38%)
  • MAPB 1,610 0 (0.00%)
  • MAPI 1,000 -15 (-1.48%)
  • MARI 185 -9 (-4.64%)
  • MARK 456 2 (0.44%)
  • MBAP 1,930 -20 (-1.03%)
  • MBSS 416 -4 (-0.95%)
  • MBTO 96 -4 (-4.00%)
  • MCAS 2,380 -20 (-0.83%)
  • MCOR 127 -3 (-2.31%)
  • MDIA 50 0 (0.00%)
  • MDKA 1,185 35 (3.04%)
  • MDKI 193 8 (4.32%) © 2010 IMQ - LKBN ANTARA
  • MDLN 197 -3 (-1.50%)
  • MEDC 750 -15 (-1.96%)
  • MEDC-W 169 -3 (-1.74%)
  • MEGA 5,150 50 (0.98%)
  • MERK 2,620 -10 (-0.38%)
  • META 190 6 (3.26%)
  • MFIN 1,270 -10 (-0.78%)
  • MFMI 444 0 (0.00%)
  • MGRO 850 5 (0.59%)
  • MICE 346 0 (0.00%)
  • MIDI 1,400 0 (0.00%)
  • MIKA 2,530 -30 (-1.17%)
  • MKNT 50 0 (0.00%)
  • MLBI 15,625 0 (0.00%)
  • MLIA 555 -5 (-0.89%)
  • MLPL 74 2 (2.78%)
  • MLPT 398 -2 (-0.50%)
  • MMLP 177 5 (2.91%)
  • MNCN 1,700 -20 (-1.16%)
  • MOLI 1,045 -5 (-0.48%)
  • MPMX 660 -10 (-1.49%)
  • MPOW 105 -1 (-0.94%)
  • MPPA 132 -1 (-0.75%)
  • MRAT 154 0 (0.00%)
  • MREI 4,000 -200 (-4.76%) © 2010 IMQ - LKBN ANTARA
  • MSIN 402 0 (0.00%)
  • MSKY 1,240 -60 (-4.62%)
  • MTDL 1,805 15 (0.84%)
  • MTFN 50 0 (0.00%)
  • MTLA 496 0 (0.00%)
  • MTPS 550 0 (0.00%)
  • MTPS-W 254 -4 (-1.55%)
  • MTRA 262 -14 (-5.07%)
  • MTSM 190 -46 (-19.49%)
  • MTWI 67 -1 (-1.47%)
  • MYOH 1,215 0 (0.00%)
  • MYOR 1,970 -15 (-0.76%)
  • MYTX 52 -3 (-5.45%)
  • NASA 620 -30 (-4.62%)
  • NATO 1,125 5 (0.45%)
  • NATO-W 820 15 (1.86%)
  • NFCX 2,800 -40 (-1.41%)
  • NICK 320 10 (3.23%)
  • NIKL 695 85 (13.93%)
  • NIRO 130 -10 (-7.14%)
  • NISP 835 -5 (-0.60%)
  • NOBU 955 30 (3.24%)
  • NRCA 346 6 (1.76%)
  • NUSA 50 0 (0.00%)
  • NUSA-W 6 -1 (-14.29%) © 2010 IMQ - LKBN ANTARA
  • NZIA 585 -105 (-15.22%)
  • NZIA-W 97 6 (6.59%)
  • OCAP 155 -21 (-11.93%)
  • OKAS 190 -7 (-3.55%)
  • OMRE 930 180 (24.00%)
  • OPMS 98 0 (0.00%)
  • PADI 50 -25 (-33.33%)
  • PALM 190 -5 (-2.56%)
  • PAMG 140 4 (2.94%)
  • PANI 96 0 (0.00%)
  • PANR 324 0 (0.00%)
  • PANS 1,385 65 (4.92%)
  • PBID 1,000 0 (0.00%)
  • PBRX 280 0 (0.00%)
  • PBSA 750 5 (0.67%)
  • PCAR 324 -14 (-4.14%)
  • PEGE 120 -32 (-21.05%)
  • PEHA 1,010 40 (4.12%)
  • PGAS 1,915 5 (0.26%)
  • PGJO 101 -6 (-5.61%)
  • PICO 800 -95 (-10.61%)
  • PJAA 920 0 (0.00%)
  • PKPK 56 -4 (-6.67%)
  • PLIN 3,150 0 (0.00%)
  • PMJS 141 -2 (-1.40%) © 2010 IMQ - LKBN ANTARA
  • PNBN 1,185 -10 (-0.84%)
  • PNBS 50 0 (0.00%)
  • PNIN 1,035 -10 (-0.96%)
  • PNLF 270 0 (0.00%)
  • POLA 171 41 (31.54%)
  • POLI 1,345 15 (1.13%)
  • POLL 10,500 0 (0.00%)
  • POLU 2,090 115 (5.82%)
  • POLY 53 1 (1.92%)
  • PORT 600 100 (20.00%)
  • POSA 50 0 (0.00%)
  • POSA-W 5 -1 (-16.67%)
  • POWR 935 -20 (-2.09%)
  • PPRE 216 0 (0.00%)
  • PPRO 59 -1 (-1.67%)
  • PRDA 3,680 -10 (-0.27%)
  • PRIM 318 -60 (-15.87%)
  • PRIM-W 32 4 (14.29%)
  • PSAB 264 8 (3.12%)
  • PSDN 180 -1 (-0.55%)
  • PSGO 170 -4 (-2.30%)
  • PSSI 174 6 (3.57%)
  • PTBA 2,410 -70 (-2.82%)
  • PTIS 92 -8 (-8.00%)
  • PTPP 1,500 -15 (-0.99%) © 2010 IMQ - LKBN ANTARA
  • PTRO 1,575 20 (1.29%)
  • PTSN 252 8 (3.28%)
  • PUDP 326 4 (1.24%)
  • PURE 228 -18 (-7.32%)
  • PURE-W 70 -5 (-6.67%)
  • PWON 570 10 (1.79%)
  • PZZA 1,075 -5 (-0.46%)
  • R-LQ45X 1,067 7 (0.66%)
  • RAJA 151 -6 (-3.82%)
  • RALS 1,165 -55 (-4.51%)
  • RANC 318 6 (1.92%)
  • RBMS 74 -2 (-2.63%)
  • RDTX 5,200 200 (4.00%)
  • REAL 418 4 (0.97%)
  • REAL-W 28 0 (0.00%)
  • RELI 130 0 (0.00%)
  • RIGS 210 6 (2.94%)
  • RIMO 50 0 (0.00%)
  • RISE 520 -20 (-3.70%)
  • RMBA 302 0 (0.00%)
  • RODA 55 2 (3.77%)
  • ROTI 1,295 5 (0.39%)
  • SAFE 206 0 (0.00%)
  • SAME 200 -6 (-2.91%)
  • SATU 70 1 (1.45%) © 2010 IMQ - LKBN ANTARA
  • SCCO 9,150 -50 (-0.54%)
  • SCMA 1,550 -30 (-1.90%)
  • SDMU 50 0 (0.00%)
  • SDPC 108 4 (3.85%)
  • SFAN 995 0 (0.00%)
  • SFAN-W 635 25 (4.10%)
  • SGRO 2,490 0 (0.00%)
  • SHID 2,700 0 (0.00%)
  • SHIP 755 -5 (-0.66%)
  • SIDO 1,225 -20 (-1.61%)
  • SILO 6,675 25 (0.38%)
  • SIMA 50 0 (0.00%)
  • SIMP 396 -6 (-1.49%)
  • SINI 1,685 -95 (-5.34%)
  • SINI-W 630 0 (0.00%)
  • SIPD 900 -95 (-9.55%)
  • SKBM 352 -14 (-3.83%)
  • SKRN 520 -20 (-3.70%)
  • SKYB 60 1 (1.69%)
  • SLIS 4,850 -30 (-0.61%)
  • SMAR 3,860 10 (0.26%)
  • SMBR 380 0 (0.00%)
  • SMCB 1,000 15 (1.52%)
  • SMDM 116 -7 (-5.69%)
  • SMDR 236 0 (0.00%) © 2010 IMQ - LKBN ANTARA
  • SMGR 13,050 75 (0.58%)
  • SMKL 224 -6 (-2.61%)
  • SMKL-W 22 -1 (-4.35%)
  • SMMT 109 -4 (-3.54%)
  • SMRA 945 -10 (-1.05%)
  • SMSM 1,425 5 (0.35%)
  • SOCI 162 -2 (-1.22%)
  • SOSS 418 0 (0.00%)
  • SOSS-W 110 25 (29.41%)
  • SOTS 216 -2 (-0.92%)
  • SOTS-W 61 -1 (-1.61%)
  • SPMA 310 -2 (-0.64%)
  • SPTO 850 10 (1.19%)
  • SQMI 288 24 (9.09%)
  • SRAJ 278 8 (2.96%)
  • SRIL 250 -2 (-0.79%)
  • SRSN 55 4 (7.84%)
  • SRTG 3,710 0 (0.00%)
  • SSIA 680 -5 (-0.73%)
  • SSMS 820 15 (1.86%)
  • STAR 157 2 (1.29%)
  • STTP 4,500 0 (0.00%)
  • SULI 51 1 (2.00%)
  • SURE 2,930 30 (1.03%)
  • SWAT 90 0 (0.00%) © 2010 IMQ - LKBN ANTARA
  • TAMU 302 -4 (-1.31%)
  • TBIG 1,200 55 (4.80%)
  • TBLA 910 10 (1.11%)
  • TBMS 835 35 (4.38%)
  • TCPI 6,875 175 (2.61%)
  • TDPM 228 8 (3.64%)
  • TEBE 1,820 5 (0.28%)
  • TELE 256 -6 (-2.29%)
  • TFAS 167 17 (11.33%)
  • TFCO 700 0 (0.00%)
  • TGRA 115 -1 (-0.86%)
  • TIFA 220 0 (0.00%)
  • TINS 775 -15 (-1.90%)
  • TIRA 300 44 (17.19%)
  • TIRT 53 0 (0.00%)
  • TKIM 10,675 -25 (-0.23%)
  • TLKM 3,880 20 (0.52%)
  • TMAS 98 0 (0.00%)
  • TOBA 370 12 (3.35%)
  • TOPS 204 -6 (-2.86%)
  • TOTL 414 2 (0.49%)
  • TOTO 260 -4 (-1.52%)
  • TOWR 830 0 (0.00%)
  • TPIA 9,800 125 (1.29%)
  • TPMA 288 0 (0.00%) © 2010 IMQ - LKBN ANTARA
  • TRIM 140 -5 (-3.45%)
  • TRIN 286 2 (0.70%)
  • TRIN-W 102 -5 (-4.67%)
  • TRIS 270 0 (0.00%)
  • TRUK 100 -3 (-2.91%)
  • TRUS 310 -10 (-3.12%)
  • TSPC 1,335 0 (0.00%)
  • TUGU 3,440 20 (0.58%)
  • TURI 905 0 (0.00%)
  • UCID 1,900 -20 (-1.04%)
  • ULTJ 1,550 -55 (-3.43%)
  • UNIT 181 20 (12.42%)
  • UNSP 99 0 (0.00%)
  • UNTR 20,350 -250 (-1.21%)
  • UNVR 8,325 25 (0.30%)
  • URBN 1,880 -30 (-1.57%)
  • URBN-W 42 -2 (-4.55%)
  • VICO 111 0 (0.00%)
  • VINS 119 0 (0.00%)
  • VINS-W 12 0 (0.00%)
  • VIVA 50 0 (0.00%)
  • VOKS 276 8 (2.99%)
  • WAPO 86 -3 (-3.37%)
  • WEGE 296 -4 (-1.33%)
  • WEHA 151 0 (0.00%) © 2010 IMQ - LKBN ANTARA
  • WICO 560 60 (12.00%)
  • WIIM 152 -4 (-2.56%)
  • WIKA 1,955 -15 (-0.76%)
  • WINS 120 -4 (-3.23%)
  • WOMF 270 -2 (-0.74%)
  • WOOD 510 0 (0.00%)
  • WOWS 161 0 (0.00%)
  • WSBP 288 -4 (-1.37%)
  • WSKT 1,305 -25 (-1.88%)
  • WTON 422 0 (0.00%)
  • XBES 1,014 2 (0.20%)
  • XBNI 1,123 5 (0.45%)
  • XCID 79 1 (1.28%)
  • XCIS 106 1 (0.95%)
  • XIHD 510 5 (0.99%)
  • XIIF 626 6 (0.97%)
  • XKIV 483 -6 (-1.23%)
  • XPMI 1,000 0 (0.00%)
  • XSSI 97 0 (0.00%)
  • YELO 75 -2 (-2.60%)
  • YELO-W 22 -1 (-4.35%)
  • ZBRA 79 -2 (-2.47%)
  • ZINC 384 -2 (-0.52%)
  • ZONE 498 -2 (-0.40%)
Takeda continues strategic divestitures with sale of select OTC and non-core assets to STADA for $660 million USD
Published: 5 Nov 2019 14:21 WIB


IMQ, Jakarta —  Transaction further accelerates deleveraging

Strengthens alignment of Growth & Emerging Markets Business Unit portfolio with Takeda’s global business areas

OSAKA, Japan--(Antara/BUSINESS WIRE)-- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it has entered into an agreement to divest a portfolio of select products to STADA Arzneimittel AG (“STADA”), an international pharmaceutical company, for a total value of $660 million USD. The portfolio includes over-the-counter (OTC) and prescription pharmaceutical products exclusively in Russia, Georgia, and a number of countries from within the Commonwealth of Independent States, which form part of Takeda’s Growth & Emerging Markets Business Unit.

This is Takeda’s fourth divestment transaction in the past six months that contributes to the Company’s goal to divest approximately $10 billion USD in non-core assets to focus on its five key business areas and commitment to accelerating its deleveraging following its acquisition of Shire. Takeda completed the divestiture of Xiidra® to Novartis for up to $5.3 billion USD in July, announced the sale of TachoSil® to Ethicon for $400 million USD in May, and last month announced its sale of non-core assets in countries spanning Near East, Middle East and Africa to Acino for over $200 million USD.

“This announcement is the latest step in Takeda’s effort to simplify our portfolio, accelerate deleveraging, and continue to invest in our key business areas. We are making strong progress towards executing our strategy and delivering enhanced value for patients and Takeda shareholders,” said Costa Saroukos, Chief Financial Officer, Takeda.

The portfolio to be divested to STADA includes OTC Vitamins and Food Supplements, plus select products within the Cardiovascular, Diabetes, General Medicine, and Respiratory therapeutic areas. The portfolio’s growth is driven by sales of products such as Cardiomagnyl, and other strong regional brands. Combined, the portfolio of products to be divested to STADA and Acino generated revenues of approximately $300 million USD in fiscal year 2018.

While these trusted products continue to play important roles in meeting patient needs, they are not within Takeda's chosen business areas – Gastroenterology, Rare Diseases, Plasma-Derived Therapies, Oncology and Neuroscience – that are core to its global long-term growth.

“Takeda remains committed to the Emerging Markets, Russia and the countries included in this agreement. We will continue to increase patient access to our portfolio of highly innovative medicines across this region through our commercial activities and Access to Medicines program,” said Ricardo Marek, President, Growth & Emerging Markets Business Unit, Takeda. “As we execute on our divestiture goals, we continue to work to ensure that each transaction aligns with Takeda’s values. We are confident that STADA is well placed to provide patients with uninterrupted access to the divested products – a top priority for Takeda – and anticipate most of the employees supporting the divested assets will be given the opportunity to transition over to STADA once the divestiture is completed.”

Takeda intends to use the proceeds from this divestiture to continue to reduce its debt and accelerate deleveraging toward its target of 2.0x net debt/adjusted EBITDA over the next three to five years. Takeda is committed to rapid deleveraging driven by strong cash flow and divestiture proceeds, while also simplifying its portfolio.

Transaction Details

Takeda has entered into an agreement to sell a portfolio of approximately 20 select OTC and prescription pharmaceutical assets sold in Russia, Georgia and countries within the Commonwealth of Independent States namely: Armenia, Azerbaijan, Belarus, Kazakhstan, and Uzbekistan to STADA – an international pharmaceutical company with a two-pillar strategy consisting of generics, including specialty pharmaceuticals and non-prescription consumer health products – for a total value of $660 million USD. Under the terms of the agreement, STADA will acquire the rights, title, and interest to the products in the portfolio exclusive to these countries.

It is anticipated that approximately 500 employees supporting the divested assets will be given the opportunity to transition over to STADA at closing. Further, Takeda and STADA will enter into manufacturing and supply agreements under which Takeda will continue to manufacture and supply the products to STADA.

The transaction is expected to close in Q4 FY19 (January- March 2020), subject to the satisfaction of customary closing conditions. Until then, the products will continue to be made avaliable to patients and manufactured and supplied by Takeda.

Takeda is being advised by BofA Securities (financial advisor) and White & Case (legal advisor) in this transaction.

About Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE: TAK) is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to bringing Better Health and a Brighter Future to patients by translating science into highly-innovative medicines. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Gastroenterology (GI), Neuroscience, and Rare Diseases. We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. We are focusing on developing highly innovative medicines that contribute to making a difference in people's lives by advancing the frontier of new treatment options and leveraging our enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline. Our employees are committed to improving quality of life for patients and to working with our partners in health care in approximately 80 countries and regions.

For more information, visit https://www.takeda.com

Forward-Looking Statements

This press release and any materials distributed in connection with this press release may contain forward-looking statements, beliefs or opinions regarding Takeda’s future business, future position and results of operations, including estimates, forecasts, targets and plans for Takeda. Without limitation, forward-looking statements often include words such as “targets”, “plans”, “believes”, “hopes”, “continues”, “expects”, “aims”, “intends”, “ensures”, “will”, “may”, “should”, “would”, “could” “anticipates”, “estimates”, “projects” or similar expressions or the negative thereof. Forward-looking statements in this document are based on Takeda’s estimates and assumptions only as of the date hereof. Such forward-looking statements do not represent any guarantee by Takeda or its management of future performance and involve known and unknown risks, uncertainties and other factors, including but not limited to: the economic circumstances surrounding Takeda’s global business, including general economic conditions in Japan and the United States; competitive pressures and developments; changes to applicable laws and regulations; the success of or failure of product development programs; decisions of regulatory authorities and the timing thereof; fluctuations in interest and currency exchange rates; claims or concerns regarding the safety or efficacy of marketed products or product candidates; the timing and impact of post-merger integration efforts with acquired companies; and the ability to divest assets that are not core to Takeda’s operations and the timing of any such divestment(s), any of which may cause Takeda’s actual results, performance, achievements or financial position to be materially different from any future results, performance, achievements or financial position expressed or implied by such forward-looking statements. For more information on these and other factors which may affect Takeda’s results, performance, achievements, or financial position, see “Item 3. Key Information—D. Risk Factors” in Takeda’s most recent Annual Report on Form 20-F and Takeda’s other reports filed with the U.S. Securities and Exchange Commission, available on Takeda’s website at: https://www.takeda.com/investors/reports/sec-filings/ or at www.sec.gov. Future results, performance, achievements or financial position of Takeda could differ materially from those expressed in or implied by the forward-looking statements. Persons receiving this press release should not rely unduly on any forward-looking statements. Takeda undertakes no obligation to update any of the forward-looking statements contained in this press release or any other forward-looking statements it may make, except as required by law or stock exchange rule. Past performance is not an indicator of future results and the results of Takeda in this press release may not be indicative of, and are not an estimate, forecast or projection of Takeda’s future results.

View source version on businesswire.com: https://www.businesswire.com/news/home/20191104006136/en/

Contacts
Investor Relations:
Takashi Okubo
+81-(0)3-3278-2306
takeda.ir.contact@takeda.com

Media Inquiries:
Sandy Rodriguez
Head, Integration & Divestiture Communications
sandy.rodriguez@takeda.com

Vince Docherty
Head, Communications, GEM Business Unit
vince.docherty@Takeda.com

Kazumi Kobayashi (Japan)
+81 (0)3-3278-2095
kazumi.kobayashi@takeda.com

Source: Takeda Pharmaceutical Company Limited
Author: Business Wire
-
POPULAR NEWS